Paranasal Sinus Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Paranasal Sinus Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma [Phase 1]
Phase 1 study evaluating IRX-2 regimen with durvalumab for incurable head and neck squamous cell carcinoma has completed, including multiple…
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating ficlatuzumab with or without cetuximab in cetuximab-resistant recurrent or metastatic head and neck squamous cell c…
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer [Phase 2]
A Phase 2 trial evaluating the combination of capecitabine and vorinostat for recurrent/metastatic head and neck squamous cell carcinomas wa…
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating lapatinib in recurrent and/or metastatic head and neck squamous cell carcinoma (including occult primary cases) has…